ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding ImageneBio, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 53 | 46 | −7 |
| Shares | 31.7M | 32.7M | +1.04M (+3.3%) |
| Value | $52.0M | $41.9M | −$10.1M (−19.4%) |
New holders (3)
Institutions that held ImageneBio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 2,515,513 | $3.22M | 0.10% |
| Aldebaran Capital, LLC | 247,795 | $317.2K | 0.30% |
| Coldstream Capital Management Inc | 525 | $672 | 0.00% |
Sold out (10)
Institutions that held ImageneBio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Marquette Asset Management, LLC | 72,890 | $119.5K |
| JBF Capital, Inc. | 72,647 | $119.1K |
| Vazirani Asset Management LLC | 25,000 | $41.0K |
| Point72 Asia (Singapore) Pte. Ltd. | 21,184 | $34.7K |
| Engineers Gate Manager LP | 18,934 | $31.1K |
| Charles Schwab Investment Management Inc | 12,304 | $20.2K |
| Tower Research Capital LLC (TRC) | 3,633 | $5.96K |
| Advisor Group Holdings, Inc. | 1,503 | $2.46K |
| Point72 (DIFC) Ltd | 564 | $926 |
| SRS Capital Advisors, Inc. | 235 | $386 |